|
|
| RD133 / IASO BIO (0 Trials) |
|
| RD137 / IASO BIO (0 Trials) |
|
| RD138 / IASO BIO (0 Trials) |
|
| RD14-01 / Imviva Biotechnologies (0 Trials) |
|
| RD15003 (insulin degludec biosimilar) / Sunshine Lake Pharma (0 Trials) |
|
| RD227 / IASO BIO (0 Trials) |
|
| RD229 / IASO BIO (0 Trials) |
|
| RD301 / IASO BIO (0 Trials) |
|
| RDD1609 / 9 Meters Biopharma (0 Trials) |
|
| RDEA436 / AstraZeneca, Bayer (0 Trials) |
|
| RDN-929 / Alkermes (0 Trials) |
|
| RDX 7675 / Ardelyx (0 Trials) |
|
| RDX009 / Ardelyx (0 Trials) |
|
| RDX011 / Ardelyx (0 Trials) |
|
| RDX013 / Ardelyx (1 Trials) |
|
| RDX023 / Ardelyx (0 Trials) |
|
| RDX024 / Ardelyx (0 Trials) |
|
| Reasanz (serelaxin) / Novartis (1 Trials) |
|
| Reatix Kit (atazanavir/ritonavir and tenofovir/emtricitabine) / Emcure (0 Trials) |
|
| rebamipide mofetil (SA001) / Samjin Pharma (0 Trials) |
|
| rebastinib (DCC-2036) / Ono Pharmaceutical (1 Trials) |
|
| Rebetron (interferon α -2b /ribavirin) / Merck (MSD), Bausch Health (0 Trials) |
|
| Rebif (human IFN-β-1a) / EMD Serono (16 Trials) |
|
| rebimastat (BMS-275291) / BMS (0 Trials) |
|
| Rebinyn (nonacog beta pegol) / Novo Nordisk (3 Trials) |
|
| rebisufligene etisparvovec (UX111) / Ultragenyx (4 Trials) |
|
| Reblozyl (luspatercept-aamt) / BMS, Merck (MSD) (63 Trials) |
|
| RebmAb 100 / Recepta (0 Trials) |
|
| rebonuputemcel (IDCT) / DiscGenics (0 Trials) |
|
| reboxetine / Generic mfg. (5 Trials) |
|
| reboxetine (AXS-12) / Axsome Therap (0 Trials) |
|
| reboxetine/oxybutynin (AD128) / Apnimed (0 Trials) |
|
| Rebyota (fecal microbiota, live-jslm) / Ferring (1 Trials) |
|
| Rebys (HSP Gp96 vaccine) / Cure & Sure Biotech (2 Trials) |
|
| REC-02 / Recardio (0 Trials) |
|
| REC-1170204 / Recursion Pharma (0 Trials) |
|
| REC-2282 / Recursion Pharma (1 Trials) |
|
| REC-4881 / Recursion Pharmaceuticals (1 Trials) |
|
| REC-617 / Recursion Pharmaceuticals (0 Trials) |
|
| Rec-LCAT / Amgen (0 Trials) |
|
| REC601 / Jiangsu Rec-Biotech (0 Trials) |
|
| REC602 / Jiangsu Rec-Biotech (0 Trials) |
|
| REC603 / Jiangsu Rec-Biotech (0 Trials) |
|
| REC604a / Jiangsu Rec-Biotech (0 Trials) |
|
| REC604b / Jiangsu Rec-Biotech (0 Trials) |
|
| Recalbon (minodronic acid) / Ono Pharma (5 Trials) |
|
| recanaclotide (IW-9179) / Ironwood Pharma (0 Trials) |
|
| Recarbrio (relebactam/imepenem/cilastatin) / Merck (MSD) (0 Trials) |
|
| recaticimab (SHR-1209) / Jiangsu Hengrui Pharma (0 Trials) |
|
| RECCE 327 / Recce Pharma (0 Trials) |
|
| RECCE 529 / The Peter Doherty Institute for Infection and Immunity, Recce Pharma, Path BioAnalytics (0 Trials) |
|
| RecD1 / UT MD Anderson Cancer Center, TGV-Labs (0 Trials) |
|
| Recentin (cediranib) / AstraZeneca (26 Trials) |
|
| Receptin (alpha-cobratoxin) / Nutra (1 Trials) |
|
| recibokibart (HB0034) / Huaota Biopharm (0 Trials) |
|
| recifercept (TA-46) / Pfizer (0 Trials) |
|
| Recofast S (salbutamol sulphate + ambroxol HCL + guaiphenesin + menthol) / Shreya Life Sci (0 Trials) |
|
| recoflavone (DA-6034) / GL PharmTech, AJU Pharm (2 Trials) |
|
| recombinant 14 valent human papillomavirus vaccine (SCT1000) / Sinocelltech (0 Trials) |
|
| recombinant acid alpha-glucosidase conjugated with AMFA / Takeda, NanoMedSyn (0 Trials) |
|
| recombinant aggrecanase-2 mAb (CRB0017) / Rottapharm Biotech (0 Trials) |
|
| recombinant alpha-fetoprotein (ACT-101) / Alpha Cancer Technologies (0 Trials) |
|
| recombinant chimeric COVID-19 epitope DC vaccine / Third Peoples Hospital of Shenzhen (0 Trials) |
|
| recombinant chimpanzee adenovirus type 155 HBV vaccine (ChAd155-hIi-HBV) / GSK (0 Trials) |
|
| recombinant coagulation factor VIII (Hemophilia A Therapeutic) / Grifols (0 Trials) |
|
| recombinant complement factor H (GEM103) / Disc Medicine (0 Trials) |
|
| recombinant DTaP / BioNet Asia (0 Trials) |
|
| recombinant ectodysplasin A1 (APO200) / Valerio Therap, Pierre Fabre (3 Trials) |
|
| recombinant exendin-4 (Uni-E4) / Uni-Bio Sci (0 Trials) |
|
| recombinant exendin-4 injection (Uni-GLP) / Uni-Bio Sci (0 Trials) |
|
| recombinant factor VIII / Insud Pharma (0 Trials) |
|
| recombinant Factor VIII (rFVIII) / Sino Biopharm (0 Trials) |
|
| recombinant follicle-stimulating hormone (AKP-501) / ASKA Pharma (0 Trials) |
|
| recombinant G-CSF / Serum Institute of India (0 Trials) |
|
| recombinant glucagon / Generic mfg. (0 Trials) |
|
| Recombinant HEPATITIS B Vaccine / Bio Farma Indonesia (0 Trials) |
|
| recombinant hepatitis B vaccine (Hansenula polymorpha) / Sinovac (0 Trials) |
|
| recombinant hepatitis B vaccine (Hansenula polymorpha) / Dalian Hissen Bio-pharm (0 Trials) |
|
| recombinant herpes zoster vaccine (CHO Cells) / MaxHealth Biotech (0 Trials) |
|
| recombinant human acid ceramidase (ACG-801) / Aceragen (0 Trials) |
|
| Recombinant Human Adv-p5 / Hualan Biological Engineering, Guangzhou N Biomedical Technology (0 Trials) |
|
| recombinant human alkaline phosphatase (rhuAP) / CEVEC, Lonza (0 Trials) |
|
| recombinant human alkaline phosphatase intravenous (recAP) / AM Pharma (1 Trials) |
|
| Recombinant human alpha 1-antitrypsin SC / Precigen (0 Trials) |
|
| recombinant human alpha-1 antitrypsin (rhAAT) / LFB SA (0 Trials) |
|
| recombinant human alpha-1-antitrypsin biotherapeutic / Promosome (0 Trials) |
|
| recombinant human anti-OX40 mAb / Livzon Pharma (0 Trials) |
|
| recombinant human arylsulfatase A (TAK-611) / Takeda (2 Trials) |
|
| recombinant human beta defensin-2 (beta defensin 2) / Planton (0 Trials) |
|
| recombinant human bone morphogenetic protein 4 (HS214) / Stemgen (0 Trials) |
|
| recombinant human chorionic gonadotropin beta (FE 999302) / Ferring (0 Trials) |
|
| recombinant human Complement Receptor Type 1 (CDX-1135) / Celldex (0 Trials) |
|
| recombinant human erythropoietin / Max Planck Institute, Pfizer (1 Trials) |
|
| recombinant human erythropoietin (rHuEPO) / XTL Biopharma (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Advanced Gene Technology (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Cristalia (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Hua-Bao Pharma (2 Trials) |
|
| recombinant human erythropoietin biosimilar / DPS Medical (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Chengdu Di’ao (0 Trials) |
|
| recombinant human erythropoietin biosimilar / ScinoPharm Taiwan (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Hindustan Antibiotics (1 Trials) |
|
| recombinant human erythropoietin biosimilar / Micro Labs (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Beijing Four Rings Biopharma (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Dongbao Enterprise Group (0 Trials) |
|
| recombinant human erythropoietin biosimilar / Huexin Kirin Kunpeng (0 Trials) |
|
| recombinant human factor VIII (rhFVIII) / ProFactor Pharma (0 Trials) |
|
| recombinant human follistatin-288 (PB01) / Paranta (0 Trials) |
|
| recombinant human G-CSF / Octapharma (0 Trials) |
|
| recombinant human heparan N-sulfatase (SHP610) / Takeda (0 Trials) |
|
| recombinant human HGF (E3112) / Eisai (0 Trials) |
|
| recombinant human Hsp110-gp100 chaperone complex vaccine / National Cancer Institute, Roswell Park Comprehensive Cancer Center (0 Trials) |
|
| recombinant human insulin (RH Insulin) / Sunshine Lake Pharma (0 Trials) |
|
| recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70% / United Laboratories (0 Trials) |
|
| recombinant human insulin biosimilar 50% + isophane insulin biosimilar 50% / United Laboratories (0 Trials) |
|
| recombinant human interferon α-2b biosimilar / Beijing Kawin (0 Trials) |
|
| recombinant human interferon α1β / Tongji University (0 Trials) |
|
| recombinant human Interleukin-12 (AM0012) / Eli Lilly (0 Trials) |
|
| recombinant human Interleukin-15 (AM0015) / Eli Lilly (0 Trials) |
|
| recombinant human matrix metalloproteinase (KTP-001) / Teijin, Meiji Seika (0 Trials) |
|
| recombinant human plasma gelsolin (rhu-pGSN) / BioAegis Therap (0 Trials) |
|
| recombinant human serum albumin (RU-10) / Mallinckrodt (0 Trials) |
|
| recombinant human somatropin (CP016) / Critical Pharma (0 Trials) |
|
| recombinant human thyroid stimulating hormone for injection (rhTSH) / Suzhou Zelgen (0 Trials) |
|
| recombinant human α-galactosidase A (GC1119) / GC Biopharma (0 Trials) |
|
| recombinant human-alpha-galactosidase / Pharming Group (0 Trials) |
|
| recombinant immunoglobulin (rIVIG) / Grifols (0 Trials) |
|
| recombinant lactoferrin (VEN120) / Ventria (2 Trials) |
|
| recombinant lipase (CDX-7108) / Codexis, Nestle (0 Trials) |
|
| recombinant lubricin (ECF843) / Dompe, Lubris BioPharma (0 Trials) |
|
| recombinant LVS ΔcapB – vectored vaccine expressing multiple SARS-CoV-2 antigens / UCLA (0 Trials) |
|
| recombinant Mycobacterium Bovis BCG vector based coronavirus vaccine / Nascent Biotech, Manhattan BioSolutions (0 Trials) |
|
| recombinant N-sulphoglucosamine sulphohydrolase (AGT184) / JCR Pharma (0 Trials) |
|
| recombinant oligo adenylate synthetase / TuHURA Bio (0 Trials) |
|
| recombinant osteoprotegerin (AMGN 0007) / Amgen (0 Trials) |
|
| recombinant parainfluenza virus 5 vaccine (BLB101) / CyanVac LLC, The University of Iowa (0 Trials) |
|
| recombinant parathyroid hormone (PTH-1-34) / Novartis (0 Trials) |
|
| recombinant PfCSP-VLP malaria vaccine / Novavax, Cadila (0 Trials) |
|
| recombinant pneumococcal protein vaccine (PBPV) / CanSino (0 Trials) |
|
| recombinant Protective Antigen Anthrax (rPA) vaccine (Px563L) / Ligand (0 Trials) |
|
| Recombinant S1-Fc fusion protein based coronavirus vaccine / AnyGo Tech (0 Trials) |
|
| recombinant SARS-CoV-2 fusion protein vaccine / Livzon Pharma, Chinese Academy of Sciences (0 Trials) |
|
| recombinant SARS-CoV-2 S-Trimer vaccine / Wuhan Binhui Biotech (0 Trials) |
|
| recombinant SeV gene Parkinson's disease vaccine / I’rom Group (0 Trials) |
|
| recombinant spike protein based vaccine with Essai O/W 1849101 adjuvant / Kazakh National Agrarian University (0 Trials) |
|
| recombinant trivalent rotavirus subunit vaccine / MaxHealth Biotech (0 Trials) |
|
| recombinant trypsinogen/chymotrypsinogen (Rec-PRP) / Propanc Biopharma (0 Trials) |
|
| Recombinant vaccine based on replicating Influenza A virus / State Research Center of Virology and Biotechnology Vector (0 Trials) |
|
| recombinant viral macrophage inflammatory protein (rvMIP) / Guangzhou Suyuan Biotechnology (0 Trials) |
|
| recombinant VP1 / Agricultural Biotechnology Research Center (0 Trials) |
|
| recombinant zoster vaccine (BV211) / BravoVax (0 Trials) |
|
| recombinant-iduronate-2-sulfatase (JR-032) / GSK, JCR Pharma (1 Trials) |
|
| Recombivax HB (hepatitis B vaccine recombinant) / Merck (MSD) (1 Trials) |
|
| Recomodulin (recombinant thrombomodulin alfa) / Asahi Kasei Therapeutics (0 Trials) |
|
| reconstituted HDL / GC Biopharma (0 Trials) |
|
| Recorlev (levoketoconazole) / Xeris Biopharma (1 Trials) |
|
| ReCOV (recombinant two-component COVID-19 vaccine (CHO cell)) / Jiangsu Rec-Biotech (0 Trials) |
|
| Rectiv (nitroglycerin) / Kyowa Kirin, Endo (2 Trials) |
|
| Redacid (cinnamomum burmannii) / Dexa Medica Group (1 Trials) |
|
| Redemplo (plozasiran) / Arrowhead Pharmaceuticals (0 Trials) |
|
| Redesca (low molecular weight heparin biosimilar) / Valeo Pharma (0 Trials) |
|
| Redimune (intravenous normal human immunoglobulin) / CSL Behring (0 Trials) |
|
| RediTrex (methotrexate) / Cumberland, Nordic Group (0 Trials) |
|
| reduced dose Tdap vaccine / BioNet Asia (0 Trials) |
|
| REDX05358 / Jazz (0 Trials) |
|
| REDX08087 / Redx (0 Trials) |
|
| refametinib (BAY86-9766) / AstraZeneca (1 Trials) |
|
| refanezumab (GSK249320) / GSK (1 Trials) |
|
| REG-101 / Regio Biosciences (2 Trials) |
|
| Regabatin (pregabalin XR) / IntellipharmaCeutics (0 Trials) |
|
| regdanvimab inhalation (IN-006) / Inhalon, Celltrion (0 Trials) |
|
| REGEN-COV (casirivimab/imdevimab) / Regeneron (0 Trials) |
|
| RegeneCyte / StemCyte (0 Trials) |
|
| Regia / Aytu BioPharma (0 Trials) |
|
| Regkirona (regdanvimab) / Celltrion (0 Trials) |
|
| REGN1154 / Regeneron (0 Trials) |
|
| REGN1400 / Regeneron (0 Trials) |
|
| REGN14284 / Regeneron (0 Trials) |
|
| REGN15160 / Regeneron (0 Trials) |
|
| REGN2009 / Regeneron (0 Trials) |
|
| REGN4336 / Regeneron (0 Trials) |
|
| REGN4659 / Regeneron (0 Trials) |
|
| REGN5069 / Regeneron (0 Trials) |
|
| REGN5093-M114 / Regeneron (0 Trials) |
|
| REGN5381 / Regeneron (0 Trials) |
|
| REGN5381/REGN9035 / Regeneron (0 Trials) |
|
| REGN5668 / Regeneron (0 Trials) |
|
| REGN5713-5714-5715 / Regeneron (0 Trials) |
|
| REGN5837 / Regeneron (0 Trials) |
|
| REGN6490 / Regeneron (0 Trials) |
|
| REGN6569 / Regeneron (1 Trials) |
|
| REGN7257 / Regeneron (0 Trials) |
|
| REGN728 / Sanofi, Regeneron (0 Trials) |
|
| REGN846 / Regeneron (0 Trials) |
|
| REGPARA / Kyowa Kirin (0 Trials) |
|
| RegStem (autologous mesenchymal stromal cell therapy) / EMO Biomedicine Corp (0 Trials) |
|
| regulatory T cell therapy / Precigen (0 Trials) |
|
| REGV131-LNP1265 / Intellia Therap, Regeneron (0 Trials) |
|
| Reiferon (hansenula-derived recombinant interferon alpha 2a biosimilar) / MinaPharm (0 Trials) |
|
| Reiferon retard (pegylated hansenula-derived recombinant interferon alpha 2a) / MinaPharm, Dynavax (0 Trials) |
|
| ReJoin (human adipose-derived mesenchymal progenitor cells) / AbelZeta Pharma (2 Trials) |
|
|